Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.681
+0.161 (10.57%)
Jun 6, 2025, 2:54 PM - Market open

Marker Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
5.76.593.313.511.240.47
Upgrade
Revenue Growth (YoY)
71.53%99.06%-5.76%182.96%166.01%118.95%
Upgrade
Cost of Revenue
14.0313.4710.4211.9727.7918.88
Upgrade
Gross Profit
-8.33-6.88-7.11-8.45-26.55-18.41
Upgrade
Selling, General & Admin
4.394.247.4811.3412.9210.47
Upgrade
Operating Expenses
4.394.247.4811.3412.9210.47
Upgrade
Operating Income
-12.72-11.12-14.58-19.79-39.48-28.89
Upgrade
Interest & Investment Income
0.440.440.540.250.010.15
Upgrade
Other Non Operating Income (Expenses)
-----0.03
Upgrade
EBT Excluding Unusual Items
-12.28-10.68-14.04-19.54-39.47-28.71
Upgrade
Other Unusual Items
-0.45---0.23-2.41-
Upgrade
Pretax Income
-12.73-10.68-14.04-19.78-41.88-28.71
Upgrade
Income Tax Expense
0.050.050---
Upgrade
Earnings From Continuing Operations
-12.78-10.73-14.05-19.78-41.88-28.71
Upgrade
Earnings From Discontinued Operations
--5.81-10.15--
Upgrade
Net Income
-12.78-10.73-8.24-29.93-41.88-28.71
Upgrade
Net Income to Common
-12.78-10.73-8.24-29.93-41.88-28.71
Upgrade
Shares Outstanding (Basic)
1099885
Upgrade
Shares Outstanding (Diluted)
1099885
Upgrade
Shares Change (YoY)
7.64%1.94%5.49%9.16%62.64%3.19%
Upgrade
EPS (Basic)
-1.34-1.19-0.94-3.58-5.47-6.10
Upgrade
EPS (Diluted)
-1.34-1.19-0.94-3.59-5.47-6.10
Upgrade
Free Cash Flow
-12.57-10.91-16.44-26.97-30.41-29.29
Upgrade
Free Cash Flow Per Share
-1.32-1.22-1.87-3.23-3.98-6.23
Upgrade
Gross Margin
-146.28%-104.33%-214.60%-240.64%--
Upgrade
Operating Margin
-223.40%-168.69%-440.37%-563.28%-3179.32%-6188.25%
Upgrade
Profit Margin
-224.44%-162.82%-248.76%-851.87%-3372.68%-6149.74%
Upgrade
Free Cash Flow Margin
-220.73%-165.53%-496.51%-767.66%-2449.11%-6274.32%
Upgrade
EBITDA
---11.79-17-37.33-28.4
Upgrade
D&A For EBITDA
--2.792.792.150.49
Upgrade
EBIT
-12.72-11.12-14.58-19.79-39.48-28.89
Upgrade
EBIT Margin
-223.40%-168.69%----
Upgrade
Revenue as Reported
5.76.593.313.511.240.47
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q